Alx Oncology Holdings Inc (ALXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 0 | 0 | 0 | 0 | 1,182 |
| Cost of Goods | N/A | N/A | N/A | N/A | 1,075 |
| Gross Profit | N/A | N/A | N/A | N/A | 107 |
| Operating Expenses | 142,467 | 170,278 | 127,436 | 83,555 | 43,845 |
| Operating Income | -142,467 | -170,278 | -127,436 | -83,555 | -43,663 |
| Interest Expense | 1,729 | 1,565 | 238 | 13 | 0 |
| Other Income | 9,346 | 11,038 | 4,256 | 84 | -1,836 |
| Pre-tax Income | -134,850 | -160,805 | -123,418 | -83,484 | -45,499 |
| Income Tax | N/A | N/A | 64 | -21 | 241 |
| Net Income Continuous | -134,850 | -160,805 | -123,482 | -83,463 | -45,740 |
| Net Income | $-134,850 | $-160,805 | $-123,482 | $-83,463 | $-45,740 |
| EPS Basic Total Ops | -2.58 | -3.74 | -3.03 | -2.07 | -2.76 |
| EPS Basic Continuous Ops | -2.58 | -3.74 | -3.03 | -2.07 | -2.47 |
| EPS Diluted Total Ops | -2.58 | -3.74 | -3.03 | -2.07 | -2.76 |
| EPS Diluted Continuous Ops | -2.58 | -3.74 | -3.03 | -2.07 | -2.47 |
| EPS Diluted Before Non-Recurring Items | -2.58 | -3.74 | -3.03 | -2.07 | -2.37 |
| EBITDA(a) | $-145,987 | $-175,679 | $-127,990 | $-83,504 | $-43,040 |